When immune cells lose orientation – and the environment imprints the genome

The epidemic of overreaction

Asthma, eczema, hay fever, and food allergies are rising dramatically worldwide, especially in industrialized nations. This “epidemic of overreaction” is not explained by genes alone, but by a disturbed balance between innate defense, acquired tolerance, and epigenetic imprinting.

Today, more than 30% of children in Western societies suffer from at least one allergic condition. Asthma alone affects around 10%—and numbers continue to grow. Genetics cannot account for this steep increase.

Allergy is not inherited—it is learned

Genes may provide predisposition (e.g., HLA variants, IL-4R polymorphisms), but actual expression is shaped epigenetically. Early-life environmental factors strongly influence immune programming:

Cesarean section vs. vaginal birth
Early cord clamping and lack of breastfeeding
Over-hygienic environments with reduced microbial exposure
Antibiotic use in childhood
Urban lifestyle with little contact to nature

Such environmental cues are written into the immune epigenome—especially during the neonatal period and early childhood, the very phase when the immune system is “learning” to distinguish friend from foe.

TH2 dominance – the epigenetic misprogramming of tolerance

Allergic disease is marked by an exaggerated TH2 response—a type of immunity meant to fight parasites, but in allergy redirected toward harmless triggers like pollen or food proteins.

Epigenetic hallmarks in allergic individuals:

Hypermethylation of Treg-related genes → suppression of tolerance mechanisms
Hypomethylation of IL-4, IL-5, and IL-13 → TH2 cytokine overexpression
Histone modifications that enhance inflammatory gene expression in mast cells
miR-21 and miR-155 upregulation → fueling allergic inflammation

Asthma patients, for instance, often show increased expression of CHI3L1, regulated by promoter demethylation—a potential biomarker.

Prenatal imprinting: Airways programmed before birth

The lungs and airways acquire epigenetic signatures already in utero. Environmental influences during pregnancy include:

Maternal smoking: DNA methylation in AHRR (Aryl Hydrocarbon Receptor Repressor), affecting lung development
Air pollution (PM2.5, NO₂): histone modifications in bronchial epithelial cells
Maternal stress: altered methylation of NR3C1 (glucocorticoid receptor), impairing anti-inflammatory control

Thus, both the ecological and emotional environment of pregnancy shapes the child’s later allergy risk—an epigenetic inheritance of circumstance.

The microbiome as teacher of the immune system

The infant microbiome—gut, skin, airways—is a critical educator of immune balance. It acts via:

Short-chain fatty acids (SCFAs) that serve as epigenetic modulators (HDAC inhibition, histone acetylation)
Induction of regulatory T cells (Tregs) to maintain immune tolerance
Modulation of miRNAs and methylation profiles in mucosal cells

A disrupted microbiome (due to C-section, lack of breastfeeding, or antibiotics) deprives the immune system of essential training—laying the foundation for allergies.

Psychoepigenetics – emotional breathlessness

Asthma and allergies are also psychosomatic in their imprint. Early-life stress leaves epigenetic traces that can alter airway regulation:

Reduced methylation of FKBP5 → dysregulated stress response
Cortisol resistance → persistent airway inflammation
Stress hormones fostering TH2 skewing

For some children, asthma becomes more than airway hyperreactivity—it is “breathlessness of attachment,” an immune reflection of emotional insecurity.

Therapeutic potentials – reprogramming tolerance

Emerging therapies target not only symptoms but the underlying epigenetic miscalibration:

Strategy	Mechanism	Example / Evidence
Probiotics & prebiotics	SCFAs → Treg modulation	Reduced allergy risk in infant studies
Polyphenols (curcumin, EGCG)	Histone modulation, DNMT inhibition	In vitro anti-inflammatory
Omega-3 fatty acids	Alter miRNA & methylation patterns	Protective in pregnancy cohorts
Mindfulness & secure attachment	Stress-axis epigenetics	Lower asthma prevalence with positive caregiving

Looking ahead, epigenetic biomarkers may allow early prediction and personalized allergy therapies—tailored to the immune system’s molecular signature.

Takeaway – Allergy as a learned misinterpretation

Asthma and allergies are not genetic destinies but epigenetic misunderstandings: miswritten immune memories shaped by environment, microbes, and stress.

“The immune system remembers—but sometimes it remembers the wrong things.”
Healing means rewriting the script toward tolerance.

Eduard Rappold

Note: This information is provided for educational purposes only and does not replace professional medical advice. Always consult qualified healthcare professionals for medical concerns.

shop

NUGENIS specializes in epigenetically active nutritional supplements.

Eduard Rappold

Dr. Eduard Rappold, MSc ist ein erfahrener Forscher und Arzt, der sich seit Jahrzehnten für geriatrische PatientInnen einsetzt. In seinem Bemühen für Alzheimer-Erkrankte eine immer bessere Versorgung zu ermöglichen, wurde er 2003 mit dem Gesundheitspreis der Stadt Wien für das Ernährungszustandsmonitoring von Alzheimer-Kranken ausgezeichnet. Im Zuge seines Masterstudiums der Geriatrie hat er seine Entwicklung des Epigenetic Brain Protector wissenschaftlich fundiert und empirisch überprüft. Im September 2015 gründete er NUGENIS, ein Unternehmen, mit dem er Wissenschaft und Anwendung zusammenbringen möchte. Damit können Menschen unmittelbar von den Ergebnissen der Angewandten Epigenetik für ihre Gesundheit profitieren. Mit dem Epigenetic Brain Protector hat Dr. Eduard Rappold, MSc bereits für internationales Aufsehen gesorgt – auf der international wichtigsten Innovationsmesse, der iENA, wurde er 2015 mit einer Goldmedaille für hervorragende Leistungen zum Schutz vor Neurodegeneration ausgezeichnet. Auf den Webseiten nugenis.eu, epigenetik.at, spermidine-soyup.com und facebook.com/nugenis können Themen zur Epigenetik und Aktuelles nachgelesen werden.